Visit our exhibitors’ booths throughout the conference and collect stamps in order to enter our Prize Draw and be in for a chance of winning Apple devices or Amazon vouchers. The Prize Draw will take place in the Exhibition Hall, make sure you don’t miss out!
Archives: Agenda
Morning refreshments and networking break
Importance of forecasting clinical trial enrollment: an AI enabled approach to increase confidence in feasibility and execution
- Learn how to pressure-test site footprint through predictive analytics by forecasting enrollment at the country and site level
- Discover methods to run re-forecasts based on actual study performance for more accurate tracking and adjustments as necessary
- Gain competitive advantage thru actionable insights to remain agile and avoid costly enrollment delays
- Learn how to leverage data to identify low-performing sites earlier in the trial process to implement effective risk mitigation tactics
Exploring the UAE’s clinical research landscape: unlocking opportunities and driving innovation
- The UAE as a prominent hub for research and clinical trials, driven by a focus on healthcare innovation and patient-centric approaches
- The UAE’s comprehensive regulatory framework that supports and facilitates clinical research
- Training and upskilling local researchers and clinicians in research methodologies
- Prioritizing patient-centric approach, engaging patient communities and advocacy groups
PSI’s VISIONAL: enhancing feasibility and enrollment predictions with GenAI
- Explore how PSI integrates GenAI for protocol similarity searches and enrollment rate predictions, improving accuracy and efficiency in clinical trial planning
- Learn how VISIONAL™ incorporates three new data sources to enhance site performance analysis and offer insights across 56 countries, supporting better decision-making
- Discover how VISIONAL™ enables sponsors to quickly generate multi-country feasibility scenarios and budgets in under 30 minutes, streamlining the planning process
Beyond Integration: How AI Creates a Clinical Trial Platform
- The challenge: Disconnected systems creating blind spots in trial management
- The opportunity: AI as the connective tissue between documentation and execution
- The Intelligent Trial Assistant: Natural Language Queries Across ETMF and CTMS
- AI-Driven Inspection Readiness: Connecting Document Quality to Trial Execution
- Predictive Trial Health: Using AI to Connect the Dots Between Documents and Operations
- Smart Document Classification Meets Smart Workflow: End-to-End Trial Automation
Morning refreshments and networking break
PANEL: How to lay the groundwork for a successful rare disease trial through early patient engagement
- Working closely with patients, caregivers and advocacy groups in clinical trial design
- The importance of building a close relationship with patients for trials where patients are the expert in their disease
- Reducing the financial burden of clinical trial participation on patients
- How to make trial participation easier on patients: where are the main hurdles impacting enrolment?
- Building long term relationships with patients post clinical trials
Beyond the Middleman: Strategic Outsourcing of IOR/EOR for Global Clinical Trials
- Demystifying the Importer of Record (IOR) and Exporter of Record (EOR) functions and reframing it as a strategic enabler of cost efficiency, regulatory compliance, and accelerated timelines in global clinical trial logistics
- What IOR/EOR really means in a clinical context: Role in customs declarations, tax responsibility, and compliance.
- IOR providers’ responsibilities through HS classification, valuation review, and pre-clearance planning.
- Best-fit model: When and where to outsource vs. manage in-house.
- Tax pitfalls in outsourced IOR: Misclassification of goods (e.g., placebo vs. commercial drug), overpaying duties or VAT due to poor documentation control, and ignoring the available tax saving opportunities.
- Tax planning by design: The importance of implementing a sound IOR strategy to avoid the highlighted tax pitfalls.
- Walk away with a deeper understanding of IOR/EOR as a strategic lever for improved global clinical execution, guidance on how to incorporate an outsourced IOR for global clinical trials and a “Red Flag Checklist” with critical questions to vet vendors for outsourcing IOR/EOR
CASE STUDY: Improving patient and site experience for rare disease trials
- Sponsors’ roles in supporting sites in order to increase trial efficiency and decrease overall timelines
- Where can clinical trial sponsors better support patients with rare diseases both during trials and in the long term?
- Lessons learned from Moderna’s experience of site and patient engagement during clinical trials